TNFR1-inhibiting cyclic peptide with unnatural amino acid structure

WO2026116212A1PCT designated stage Publication Date: 2026-06-04ASAHI KASEI PHARMA CORP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
ASAHI KASEI PHARMA CORP
Filing Date
2025-11-20
Publication Date
2026-06-04

Smart Images

  • Figure JP2025040566_04062026_PF_FP_ABST
    Figure JP2025040566_04062026_PF_FP_ABST
Patent Text Reader

Abstract

Provided is a cyclic peptide represented by general formula (1) that selectively binds to TNFR1 and contains an unnatural amino acid structure having excellent TNFR1 inhibitory activity.
Need to check novelty before this filing date? Find Prior Art